Representative Julie Johnson (D-Texas) recently sold shares of Cigna Group (NYSE:CI). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cigna Group stock on December 18th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.
Representative Julie Johnson also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of Philip Morris International (NYSE:PM) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of Bank of America (NYSE:BAC) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 12/18/2025.
- Sold $1,001 – $15,000 in shares of Republic Services (NYSE:RSG) on 12/18/2025.
Cigna Group Stock Performance
Shares of CI stock opened at $272.29 on Monday. The company has a market capitalization of $72.74 billion, a price-to-earnings ratio of 12.01, a P/E/G ratio of 0.96 and a beta of 0.26. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $273.63 and its 200-day simple moving average is $286.84.
Cigna Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were issued a dividend of $1.51 per share. The ex-dividend date was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is currently 26.64%.
Analysts Set New Price Targets
A number of brokerages recently commented on CI. UBS Group set a $294.00 price objective on shares of Cigna Group in a research report on Wednesday, November 12th. The Goldman Sachs Group lowered their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. Wolfe Research dropped their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Leerink Partners reduced their price objective on Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. Finally, Cowen set a $333.00 target price on Cigna Group in a research note on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $330.48.
Check Out Our Latest Stock Analysis on Cigna Group
Hedge Funds Weigh In On Cigna Group
Several institutional investors have recently bought and sold shares of the stock. Harbor Capital Advisors Inc. increased its holdings in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares during the last quarter. Beacon Financial Strategies CORP bought a new stake in Cigna Group during the fourth quarter worth approximately $28,000. Solstein Capital LLC bought a new stake in Cigna Group during the second quarter worth approximately $29,000. Chilton Capital Management LLC acquired a new position in Cigna Group during the second quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC raised its position in shares of Cigna Group by 115.6% in the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 52 shares during the period. 86.99% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Cigna Group
In other news, CEO David Cordani acquired 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average cost of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.70% of the company’s stock.
About Representative Johnson
Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.
Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
